Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Mangalam Drugs And Organics Limited (NSE: MANGALAM), ISIN INE584F01014 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
MANGALAM last traded at ₹32.31 (-0.22%), with a 52-week range of ₹22.70 to ₹77.90 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 35.65%, FIIs 0.11%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 32/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.